B. Braun Announces Availability of 15% Amino Acids Injection
FDA approval helps ease supply shortages experienced by pharmacy admixture programs
Bethlehem, PA – June 04, 2012 − B. Braun Medical Inc. (B. Braun) announced today that they have received FDA approval to supply 1 liter 15% Amino Acids Injection. The news comes at a time when pharmacy admixture programs across the nation are challenged to find all of the essential ingredients.
“Having a new source for 15% Amino Acids may give healthcare providers one less thing to worry about,” said Rob Albert, Senior Vice President and Chief Marketing Officer. For more information on 15% Amino Acids you can phone 800-227-2862, email firstname.lastname@example.org or contact your local B. Braun representative.
About B. Braun
B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company’s “Sharing Expertise®” philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.
Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at email@example.com or visit B. Braun at www.bbraunusa.com.